<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">3 Biotech</journal-id><journal-id journal-id-type="iso-abbrev">3 Biotech</journal-id><journal-title-group><journal-title>3 Biotech</journal-title></journal-title-group><issn pub-type="ppub">2190-572X</issn><issn pub-type="epub">2190-5738</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7885310</article-id><article-id pub-id-type="publisher-id">2672</article-id><article-id pub-id-type="doi">10.1007/s13205-021-02672-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Reports</subject></subj-group></article-categories><title-group><article-title>In vitro antimycobacterial studies of flavonols from <italic>Bauhinia vahlii</italic> Wight and Arn</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9554-9092</contrib-id><name><surname>Nguyen</surname><given-names>Thanh-Trung</given-names></name><address><email>trungnt@duytan.edu.vn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7229-8761</contrib-id><name><surname>Ketha</surname><given-names>Alekhya</given-names></name><address><email>kethaalekhya@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2998-1415</contrib-id><name><surname>Hieu</surname><given-names>Ho Viet</given-names></name><address><email>hoviethieu@duytan.edu.vn</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9376-1911</contrib-id><name><surname>Tatipamula</surname><given-names>Vinay Bharadwaj</given-names></name><address><email>vinaybharadwajtatipamula@duytan.edu.vn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.444918.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 7022</institution-id><institution>Institute of Research and Development, </institution><institution>Duy Tan University, </institution></institution-wrap>Da Nang, 550000 Vietnam </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.444918.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 7022</institution-id><institution>Faculty of Pharmacy, </institution><institution>Duy Tan University, </institution></institution-wrap>Da Nang, 550000 Vietnam </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411381.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0728 2694</institution-id><institution>Pharmaceutical Chemistry Department, </institution><institution>AU College of Pharmaceutical Sciences, Andhra University, </institution></institution-wrap>Visakhapatnam, 530003 India </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.444918.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 7022</institution-id><institution>Department of Medical Microbiology and Parasitology, Faculty of Medicine, </institution><institution>Duy Tan University, </institution></institution-wrap>Da Nang, 550000 Vietnam </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2021</year></pub-date><volume>11</volume><issue>3</issue><elocation-id>128</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; King Abdulaziz City for Science and Technology 2021</copyright-statement></permissions><abstract id="Abs1"><p id="Par1">Mycobacterial infections and fast-growing strains are increasing globally with 8 million new cases and 1.8 million fatalities per annum worldwide. The acid-fast bacterium, <italic>Mycobacterium tuberculosis</italic> (<italic>M.t</italic>), can spread diseases like tuberculosis (Tb) and weaken the immune system. In Ayurveda, the <italic>Bauhinia</italic> genus is most valued for the treatment of tuberculosis lymphadenitis. The objective of the present study is to identify anti-tubercular compounds from the under-investigated medicinal plant <italic>B. vahlii</italic> Wight and Arn. using bioassay guided isolation. The antimycobacterial activity was evaluated against non-virulent strains: <italic>Mycobacterium tuberculosis</italic> H37Ra (ATCC 25177) and <italic>Mycobacterium bovis</italic> BCG (ATCC 35743). Also, antibacterial and cytotoxicity activities were tested to identify the specificity of the isolated metabolites. Bioassay-guided isolation yielded three known flavonols, namely quercetin <bold>(1)</bold>, ombuin <bold>(2)</bold>, and kaempferol <bold>(3),</bold> from the methanolic extract of bark of <italic>B. vahlii</italic>. The results of antimycobacterial activity tests revealed that <bold>2</bold> showed much better mycobactericidal activity than 1 and 3 under ex vivo condition with minimum inhibitory concentration (MIC) values ranged from 0.05&#x02009;&#x000b1;&#x02009;0.01 to 0.26&#x02009;&#x000b1;&#x02009;0.01&#x000a0;nM, and half-maximal inhibitory concentration (IC<sub>50</sub>) values ranged from 2.85&#x02009;&#x000b1;&#x02009;0.14 to 7.21&#x02009;&#x000b1;&#x02009;1.09&#x000a0;nM against dormant and active forms, respectively. Also, compound <bold>2</bold> showed higher resistance with MIC values&#x02009;&#x0003e;&#x02009;100&#x000a0;&#x003bc;g/mL against both Gram-positive and Gram-negative bacteria and the least cytotoxicity up to 100&#x000a0;&#x003bc;g/mL concentration against the tested series of cancer cell lines. The results revealed the Ayurvedic use of extracts of the <italic>Bauhinia</italic> genus for treating tuberculosis, and the key bioactive compounds were found to be flavonols <bold>(1&#x02013;3)</bold>. The present work provides the first evidence for the presence of antimycobacterial compounds in <italic>B. vahlii</italic>.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s13205-021-02672-4.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Antibacterial activity</kwd><kwd>Antimycobacterial activity</kwd><kwd><italic>B. vahlii</italic></kwd><kwd>Cytotoxicity</kwd><kwd>Flavonols</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; King Abdulaziz City for Science and Technology 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Acid-fast bacilli, <italic>Mycobacterium tuberculosis</italic> (<italic>M.t</italic>), is a huge threat to human health. The acid-fast bacterium can spread diseases like tuberculosis (Tb) and weakens the immune system (Behr et al. <xref ref-type="bibr" rid="CR2">1999</xref>). However, depending on the illness, Tb requires drug therapy of antibiotics (commonly, rifampicin and isoniazid) for at least 1&#x02013;6 months (Global Tuberculosis Report <xref ref-type="bibr" rid="CR9">2020</xref>), and the side effects of many anti-Tb drugs are severe. Usually, the treatment also causes the occurrence of extremely drug-resistant and multidrug-resistant strains of <italic>M.t</italic> (Gagneux <xref ref-type="bibr" rid="CR7">2006</xref>; Paidi et al. <xref ref-type="bibr" rid="CR10">2017</xref>). According to the World Health Organization (WHO) Global Tb Programme Report <xref ref-type="bibr" rid="CR9">2020</xref>, the COVID-19 pandemic situation has had a negatively impacted on care services and detection of Tb cases globally and the mortality rate of Tb patients have also increased (Glaziou <xref ref-type="bibr" rid="CR8">2020</xref>). Therefore, Tb has been declared a global emergency by the WHO (Glaziou <xref ref-type="bibr" rid="CR8">2020</xref>; Rakotonirina et al. <xref ref-type="bibr" rid="CR12">2009</xref>). Hence, in search of alternative antimycobacterial agents, we concentrated our efforts toward screening natural sources like <italic>B. vahlii</italic> Wight and Arn. (Family: Fabaceae), against <italic>M.t</italic> strains and isolating the marker compounds.</p><p id="Par3">In Ayurveda, the bark, flowers, and roots of genus <italic>Bauhinia</italic> are most valued for the treatment of scrofula, tuberculosis lymphadenitis, worm infestation, and wounds. The broad spectrum of biological activities of this genus is mainly due to the presence of flavonols, flavanones, bibenzyls, triterpenes, flavonol-glycosides, saponins, and phenanthraquinones. The antimycobacterial activity of some flavanones and bibenzyls from <italic>Bauhinia purpurea</italic> has already been reported (Boonphong et al. <xref ref-type="bibr" rid="CR3">2007</xref>). With this background, we have presented results of bioassay-guided isolation and characterization of flavonols from <italic>B. vahlii</italic> and their antimycobacterial activity in both in vitro and ex vivo conditions.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Plant material</title><p id="Par4">Bark of <italic>B. vahlii</italic> Wight and Arn. was collected at Seshachalam hills (Tirupati), India, in Mar 2019, and a voucher specimen (DB-SVU-2019-3478) was deposited at the Department of Botany, Sri Venkateswara University, Tirupati, India.</p></sec><sec id="Sec4"><title>Extraction and bioassay-guided isolation</title><p id="Par5">Dried bark (about 250&#x000a0;g) was powdered and extracted by the maceration method (Tatipamula et al. <xref ref-type="bibr" rid="CR19">2020</xref>) using 90% methanol (3&#x02009;&#x000d7;&#x02009;500&#x000a0;mL&#x02009;&#x000d7;&#x02009;7&#x000a0;days) at 25&#x000a0;&#x02103;. All the extract was combined and evaporated under low pressure using rotavapor (Shimadzu Rotation evaporator QR 2005-S, Japan) to obtain crude methanol extract of bark of <italic>B. vahlii</italic> (<bold>ME</bold>, 4.5&#x000a0;g) as a dark black solid. <bold>ME</bold> was subsequently screened and found to be effective against <italic>M. tuberculosis</italic> (<italic>M.t</italic>) H37Ra (ATCC 25177) (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Yield and primary screening of anti-tubercular activity of methanol extract <bold>(ME)</bold>, fractions <bold>(F1&#x02013;7),</bold> and compounds <bold>(1&#x02013;3)</bold> from <italic>B. vahlii</italic> Wight and Arn</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Sample</th><th align="left" rowspan="2">Yield (mg)</th><th align="left" colspan="3">% inhibition of <italic>M.t</italic> H37Ra (ATCC 25177)<sup>a</sup></th></tr><tr><th align="left">10&#x000a0;&#x003bc;g/mL</th><th align="left">30&#x000a0;&#x003bc;g/mL</th><th align="left">100&#x000a0;&#x003bc;g/mL</th></tr></thead><tbody><tr><td align="left">ME</td><td align="left">4000</td><td char="&#x000b1;" align="char">48.63&#x02009;&#x000b1;&#x02009;1.20</td><td char="&#x000b1;" align="char">68.58&#x02009;&#x000b1;&#x02009;1.82</td><td char="&#x000b1;" align="char">81.71&#x02009;&#x000b1;&#x02009;3.10</td></tr><tr><td align="left">F1</td><td align="left">800</td><td char="&#x000b1;" align="char">2.19&#x02009;&#x000b1;&#x02009;0.30</td><td char="&#x000b1;" align="char">2.73&#x02009;&#x000b1;&#x02009;0.57</td><td char="&#x000b1;" align="char">4.80&#x02009;&#x000b1;&#x02009;0.28</td></tr><tr><td align="left">F2</td><td align="left">450</td><td char="&#x000b1;" align="char">0.69&#x02009;&#x000b1;&#x02009;0.10</td><td char="&#x000b1;" align="char">1.31&#x02009;&#x000b1;&#x02009;0.12</td><td char="&#x000b1;" align="char">2.01&#x02009;&#x000b1;&#x02009;0.79</td></tr><tr><td align="left">F3</td><td align="left">620</td><td char="&#x000b1;" align="char">9.86&#x02009;&#x000b1;&#x02009;1.02</td><td char="&#x000b1;" align="char">14.77&#x02009;&#x000b1;&#x02009;2.60</td><td char="&#x000b1;" align="char">28.49&#x02009;&#x000b1;&#x02009;0.70</td></tr><tr><td align="left">F4</td><td align="left">250</td><td char="&#x000b1;" align="char">65.07&#x02009;&#x000b1;&#x02009;1.57</td><td char="&#x000b1;" align="char">76.84&#x02009;&#x000b1;&#x02009;1.56</td><td char="&#x000b1;" align="char">90.01&#x02009;&#x000b1;&#x02009;3.06</td></tr><tr><td align="left">F5</td><td align="left">310</td><td char="&#x000b1;" align="char">16.69&#x02009;&#x000b1;&#x02009;0.79</td><td char="&#x000b1;" align="char">20.69&#x02009;&#x000b1;&#x02009;1.91</td><td char="&#x000b1;" align="char">28.49&#x02009;&#x000b1;&#x02009;0.70</td></tr><tr><td align="left">F6</td><td align="left">200</td><td char="&#x000b1;" align="char">56.69&#x02009;&#x000b1;&#x02009;2.46</td><td char="&#x000b1;" align="char">68.14&#x02009;&#x000b1;&#x02009;1.59</td><td char="&#x000b1;" align="char">90.96&#x02009;&#x000b1;&#x02009;3.72</td></tr><tr><td align="left">F7</td><td align="left">550</td><td char="&#x000b1;" align="char">18.85&#x02009;&#x000b1;&#x02009;2.81</td><td char="&#x000b1;" align="char">22.13&#x02009;&#x000b1;&#x02009;2.19</td><td char="&#x000b1;" align="char">34.21&#x02009;&#x000b1;&#x02009;4.18</td></tr><tr><td align="left">1</td><td align="left">80</td><td char="&#x000b1;" align="char">66.65&#x02009;&#x000b1;&#x02009;6.90</td><td char="&#x000b1;" align="char">80.53&#x02009;&#x000b1;&#x02009;5.88</td><td char="&#x000b1;" align="char">89.19&#x02009;&#x000b1;&#x02009;2.20</td></tr><tr><td align="left">2</td><td align="left">60</td><td char="&#x000b1;" align="char">71.22&#x02009;&#x000b1;&#x02009;5.19</td><td char="&#x000b1;" align="char">82.19&#x02009;&#x000b1;&#x02009;7.23</td><td char="&#x000b1;" align="char">93.88&#x02009;&#x000b1;&#x02009;3.90</td></tr><tr><td align="left">3</td><td align="left">50</td><td char="&#x000b1;" align="char">23.85&#x02009;&#x000b1;&#x02009;5.62</td><td char="&#x000b1;" align="char">29.29&#x02009;&#x000b1;&#x02009;4.28</td><td char="&#x000b1;" align="char">44.41&#x02009;&#x000b1;&#x02009;2.67</td></tr><tr><td align="left">Rifampicin</td><td align="left">NA</td><td char="&#x000b1;" align="char">71.02&#x02009;&#x000b1;&#x02009;0.24</td><td char="&#x000b1;" align="char">92.26&#x02009;&#x000b1;&#x02009;2.02</td><td char="&#x000b1;" align="char">96.01&#x02009;&#x000b1;&#x02009;0.64</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Mean&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;3); <italic>M.t</italic>: <italic>Mycobacterium tuberculosis</italic>, <italic>NA</italic> not applicable</p></table-wrap-foot></table-wrap></p><p id="Par6">About 3.0&#x000a0;g of <bold>ME</bold> was subjected to column chromatography (sintered disc column, 600&#x000a0;mm&#x02009;&#x000d7;&#x02009;45&#x000a0;mm; Product code: 6101067, Borosil, India) over silica gel (230&#x02013;400 mesh, CAS No.: 112926-00-8, Merck) by employing a mobile phase hexane&#x02013;ethyl acetate gradient (0&#x02013;100%) yielding seven fractions <bold>(F1-7)</bold>. These fractions were concentrated in a vacuum and screened in an antimycobacterial assay using <italic>M.t</italic> H37Ra (ATCC 25177) strain (Singh et al. <xref ref-type="bibr" rid="CR15">2015</xref>; Paidi et al. <xref ref-type="bibr" rid="CR11">2018</xref>).</p><p id="Par7">From these results, it was evident that two fractions (<bold>F4</bold> and <bold>F6</bold>) exhibited prominent inhibitory action against <italic>M.t</italic> H37Ra, suggesting further purification to identify marker compounds. <bold>F4</bold> (250&#x000a0;mg) after purification by repeated chromatography (sintered disc column, 300&#x000a0;mm&#x02009;&#x000d7;&#x02009;18&#x000a0;mm; Product code: 6101062, Borosil, India) and preparative thin-layer chromatography (TLC) (pre-coated glass silica plates, TLC-Silica gel 60 GF<sub>254</sub>, CAS: 7631-86-9, Merck, Germany) yielded <bold>1</bold> (80&#x000a0;mg). Similarly, <bold>F6</bold> (200&#x000a0;mg) after purification by repeated chromatography (sintered disc column, 300&#x000a0;mm&#x02009;&#x000d7;&#x02009;18&#x000a0;mm; Product code: 6101062, Borosil, India) using hexane&#x02013;ethyl acetate gradient (0&#x02013;100%) and preparative TLC (TLC-Silica gel 60 GF<sub>254</sub>, CAS: 7631-86-9, Merck, Germany) yielded compounds <bold>2</bold> (60&#x000a0;mg) and <bold>3</bold> (50&#x000a0;mg). Furthermore, proton (1H)-nuclear magnetic resonance (NMR) and Carbon-13 (13C)-NMR (Bruker Avance 400 Spectrometer, Germany), Mass (LC/MS Triple Quad Portfolio, Agilent, China) spectral analyses, melting point determination (M-560/565 Melting Point Apparatus, Buchi, Switzerland), and elemental analyses (2400 CHNS Organic Elemental Analyzer, PerkinElmer, USA) were applied for the structure elucidation of isolated compounds. The measurements of Mass and NMR spectrophotometers were made using Robust mass spectrometry application software (Sturm et al. <xref ref-type="bibr" rid="CR16">2008</xref>) and Bruker&#x02019;s topspin software (Baldisseri and Biospin <xref ref-type="bibr" rid="CR1">2018</xref>), respectively.</p></sec><sec id="Sec5"><title>In vitro and ex vivo antimycobacterial assay</title><p id="Par8">In the current study, antimycobacterial activity was evaluated against a non-virulent strain of <italic>M.t</italic> in a liquid medium in triplicate. Standard cultures of <italic>M.t</italic> H37Ra (ATCC 25177) and <italic>Mycobacterium bovis</italic> BCG (ATCC 35743) were procured from the American Type Culture Collection (ATCC, Manassas, Virginia). <italic>M.t</italic> and <italic>M. bovis</italic> were grown and maintained as per standard protocols (Singh et al. <xref ref-type="bibr" rid="CR15">2015</xref>; Paidi et al. <xref ref-type="bibr" rid="CR11">2018</xref>). The bark extract (<bold>ME</bold>), fractions <bold>(F1-7)</bold>, and isolated compounds <bold>(1&#x02013;3)</bold> were screened for <italic>M.t</italic> inhibitory activity at 10, 30, and 100&#x000a0;&#x003bc;g/mL concentrations using 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction menadione assay (XRMA) at 470&#x000a0;nm (Singh et al. <xref ref-type="bibr" rid="CR14">2011</xref>). The inhibition of <italic>M. bovis</italic> was estimated using nitrate reductase (NR) assay at 540&#x000a0;nm (Singh et al. <xref ref-type="bibr" rid="CR15">2015</xref>). Through dose&#x02013;response curves, minimum inhibitory concentration (MIC), and half-maximal inhibitory concentration (IC<sub>50</sub>) values were calculated against mycobacteria strains. Rifampicin was taken as a standard.</p></sec><sec id="Sec6"><title>In vitro antibacterial assay</title><p id="Par9">To determine specificity, compounds <bold>1&#x02013;3</bold> at 0.1, 0.3, 1, 3, 10, 30, and 100&#x000a0;&#x003bc;g/mL concentrations were tested against bacteria strains [two Gram-positive: <italic>S. aureus</italic> (ATCC25923), <italic>B. subtilis</italic> (ATCC21332), and two Gram-negative: <italic>S. typhi</italic> (ATCC1408), <italic>E. coli</italic> (ATCC25922)] in triplicate. In a 96-well microtitre plate, 1%v/v LB broth and the optical density (OD)-adjusted culture (OD620&#x02009;=&#x02009;1) were inoculated (Dzoyem et al. <xref ref-type="bibr" rid="CR6">2013</xref>; Shetty et al. <xref ref-type="bibr" rid="CR13">2014</xref>). Then, isolated compounds <bold>(1&#x02013;3)</bold> of 2.5&#x000a0;&#x003bc;L and culture (247.5&#x000a0;&#x003bc;L) were added and incubated at 37&#x000a0;&#x000b0;C for 18&#x000a0;h. Wells for sterility control and growth were also included, and streptomycin was used as a standard. The absorbance was measured at 620&#x000a0;nm. Through dose&#x02013;response curves, MIC and IC<sub>50</sub> values were calculated against strains.</p></sec><sec id="Sec7"><title>Cytotoxicity assay</title><p id="Par10">The breast (MDA-MB-231), cervical (HT-3), and ovarian (SKOV3) cancer cell lines were procured from the National Centre for Cell Science, Pune, India, and maintained according to the standard established procedures (Chitturi et al. <xref ref-type="bibr" rid="CR4">2015</xref>, <xref ref-type="bibr" rid="CR5">2016</xref>). In vitro potential effects of compounds (<bold>1&#x02013;3</bold>) on cell death were investigated through 3-(4, 5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay in triplicate (Tatipamula and Vedula <xref ref-type="bibr" rid="CR17">2018</xref>; Tatipamula et al. <xref ref-type="bibr" rid="CR18">2019</xref>). Through dose&#x02013;response curves, IC<sub>50</sub> values were calculated against cancer cell lines.</p></sec></sec><sec id="Sec8"><title>Results and discussion</title><p id="Par11">To identify the bioactive antimycobacterial compounds from <bold>ME</bold>, it was fractionated using column chromatography, into seven fractions, namely <bold>F1&#x02013;7</bold>. They were then screened for inhibitory action against <italic>M.t</italic> H37Ra. In preliminary screening,&#x02009;~&#x02009;90% inhibition was observed for only <bold>ME, F4,</bold> and <bold>F6</bold>; others showed&#x02009;&#x0003e;&#x02009;28% inhibition against <italic>M.t</italic> H37Ra strain (Table <xref rid="Tab1" ref-type="table">1</xref>). Further purification of <bold>F4</bold> and <bold>F6</bold> yielded compounds <bold>1&#x02013;3</bold>. By elemental and spectral analysis, these compounds were identified as quercetin <bold>(1)</bold>, ombuin <bold>(2)</bold>, and kaempferol <bold>(3)</bold> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Chemical representation of isolated flavonols <bold>(1&#x02013;3)</bold> from <italic>B. vahlii</italic></p></caption><graphic xlink:href="13205_2021_2672_Fig1_HTML" id="MO1"/></fig></p><p id="Par12">Compounds <bold>1</bold> and <bold>2</bold> obtained from <bold>F4</bold> and <bold>F6</bold>, respectively, showed profound mycobactericidal strength, inhibiting&#x02009;~&#x02009;90% of mycobacterial growth. Depending upon primary screening, active compounds <bold>1</bold> and <bold>2</bold> at a concentration range of 0.03&#x02013;30&#x000a0;&#x003bc;g/mL were further evaluated to determine their IC<sub>50</sub> and MIC values against dormant (12&#x000a0;days&#x02019; incubation) and active (8&#x000a0;day&#x02019;s incubation) forms of <italic>M.t</italic> in both in vitro (<italic>M.t</italic> and <italic>M. bovis</italic> BCG), and ex vivo (<italic>M.t</italic>) conditions using the XRMA and NR assays. The results revealed the strong antimycobacterial activity of compounds <bold>1</bold> and <bold>2</bold> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Half-maximal inhibitory concentration (IC<sub>50</sub>) values of compounds <bold>1</bold> and <bold>2</bold> against <bold>a</bold> in vitro<italic> M. tuberculosis</italic> H37Ra; <bold>b</bold> in vitro<italic> M. bovis</italic> BCG; <bold>c</bold> ex vivo<italic> M. tuberculosis</italic> H37Ra<italic>.</italic> Minimum inhibitory concentration (MIC) values of compounds <bold>1</bold> and <bold>2</bold> against <bold>d</bold> in vitro<italic> M. tuberculosis</italic> H37Ra; <bold>e</bold> in vitro<italic> M. bovis</italic> BCG; <bold>F.</bold> ex vivo<italic> M. tuberculosis</italic> H37Ra. *Mean&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;3); Statistical analysis determined by <italic>t</italic> test where ***<italic>p</italic> &#x0003c; 0.0001 is statistically significant compared to rifampicin. IC<sub>50</sub> and MIC values are the lowest concentration of samples exhibiting percentage growth inhibition of 50% and&#x02009;&#x02265;&#x02009;90%, respectively, relative to the growth control</p></caption><graphic xlink:href="13205_2021_2672_Fig2_HTML" id="MO2"/></fig></p><p id="Par13">Compound <bold>1</bold> was found to be extremely effective in inhibiting both active and dormant forms of <italic>M. bovis</italic> BCG (in vitro), and <italic>M.t</italic> (ex vivo) with MIC values ranged from 3.21&#x02009;&#x000b1;&#x02009;0.09 to 10.26&#x02009;&#x000b1;&#x02009;0.73&#x000a0;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>e, f), and IC<sub>50</sub> values ranged from 0.13&#x02009;&#x000b1;&#x02009;0.01 to 4.90&#x02009;&#x000b1;&#x02009;0.60&#x000a0;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b, c). A higher concentration of compound <bold>1</bold> was required for complete inhibition of both active and dormant forms of <italic>M.t</italic> (in vitro) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a, d). Alternatively, compound <bold>2</bold> showed much better mycobactericidal activity under ex vivo conditions with MIC values of 0.05&#x02009;&#x000b1;&#x02009;0.01 and 0.26&#x02009;&#x000b1;&#x02009;0.01&#x000a0;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>f), and IC<sub>50</sub> values of 2.85&#x02009;&#x000b1;&#x02009;0.14 and 7.21&#x02009;&#x000b1;&#x02009;1.09&#x000a0;nM against dormant and active forms, respectively (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c). Compound <bold>2</bold> exhibited the least activity against the dormant stage of <italic>M.t</italic> (in vitro) with MIC value&#x02009;~&#x02009;300&#x000a0;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>d) and the IC<sub>50</sub> value of 15.86&#x02009;&#x000b1;&#x02009;1.10&#x000a0;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). However, the IC<sub>50</sub> value of compound <bold>2</bold> in the dormant stage of <italic>M.t</italic> (in vitro) was detected to be lesser than in its active stage. Taken together, the overall antimycobacterial activity exhibited by compounds <bold>1</bold> and <bold>2</bold> was significant, although they hold inferior potencies compared to rifampicin.</p><p id="Par14">To check the antimicrobial specificity of compounds <bold>1&#x02013;3,</bold> we tested them against two Gram-negative bacteria (<italic>S. typhi</italic> and <italic>E. coli</italic>) and two Gram-positive bacteria (<italic>S. aureus</italic> and <italic>B. subtilis</italic>). Compounds <bold>2</bold> and <bold>3</bold> showed higher resistance with MIC values&#x02009;&#x0003e;&#x02009;100&#x000a0;&#x003bc;g/mL against both Gram-positive and Gram-negative bacteria (Table <xref rid="Tab2" ref-type="table">2</xref>). Moreover, the MIC values of compound <bold>1</bold> against tested bacterial strains ranged from 69.15&#x02009;&#x000b1;&#x02009;1.30 to 151.20&#x02009;&#x000b1;&#x02009;5.10&#x000a0;nM (Table <xref rid="Tab2" ref-type="table">2</xref>). This indicates that compound <bold>2</bold> isolated from <bold>ME</bold>, has greater specificity toward mycobacteria than <bold>1</bold>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>In vitro antibacterial activity of compounds <bold>(1&#x02013;3)</bold> isolated from methanolic extract of bark of <italic>B. vahlii</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Sample</th><th align="left" colspan="2"><italic>S. aurues</italic><sup>a</sup></th><th align="left" colspan="2"><italic>B. subtilis</italic><sup>a</sup></th><th align="left" colspan="2"><italic>S. typhi</italic><sup>a</sup></th><th align="left" colspan="2"><italic>E. coli</italic><sup>a</sup></th></tr><tr><th align="left">IC<sub>50</sub></th><th align="left">MIC</th><th align="left">IC<sub>50</sub></th><th align="left">MIC</th><th align="left">IC<sub>50</sub></th><th align="left">MIC</th><th align="left">IC<sub>50</sub></th><th align="left">MIC</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">41.03&#x02009;&#x000b1;&#x02009;2.27</td><td align="left">69.15&#x02009;&#x000b1;&#x02009;1.30</td><td align="left">25.81&#x02009;&#x000b1;&#x02009;2.18</td><td align="left">131.39&#x02009;&#x000b1;&#x02009;8.00</td><td align="left">80.13&#x02009;&#x000b1;&#x02009;4.17</td><td align="left">143.73&#x02009;&#x000b1;&#x02009;7.26</td><td align="left">117.22&#x02009;&#x000b1;&#x02009;4.35</td><td align="left">151.20&#x02009;&#x000b1;&#x02009;5.10</td></tr><tr><td align="left">2</td><td align="left">287.63&#x02009;&#x000b1;&#x02009;6.36</td><td align="left">290.65&#x02009;&#x000b1;&#x02009;10.34</td><td align="left">299.74&#x02009;&#x000b1;&#x02009;9.25</td><td align="left">&#x02013;</td><td align="left">207.61&#x02009;&#x000b1;&#x02009;15.38</td><td align="left">&#x02013;</td><td align="left">223.29&#x02009;&#x000b1;&#x02009;16.70</td><td align="left">267.73&#x02009;&#x000b1;&#x02009;9.26</td></tr><tr><td align="left">3</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">Streptomycin</td><td align="left">0.34&#x02009;&#x000b1;&#x02009;0.05</td><td align="left">2.86&#x02009;&#x000b1;&#x02009;0.13</td><td align="left">16.86&#x02009;&#x000b1;&#x02009;1.13</td><td align="left">29.54&#x02009;&#x000b1;&#x02009;2.45</td><td align="left">8.10&#x02009;&#x000b1;&#x02009;0.89</td><td align="left">12.48&#x02009;&#x000b1;&#x02009;1.00</td><td align="left">1.17&#x02009;&#x000b1;&#x02009;0.13</td><td align="left">4.18&#x02009;&#x000b1;&#x02009;0.30</td></tr><tr><td align="left">Rifampicin</td><td align="left">19.44&#x02009;&#x000b1;&#x02009;1.04</td><td align="left">36.45&#x02009;&#x000b1;&#x02009;2.00</td><td align="left">0.30&#x02009;&#x000b1;&#x02009;0.03</td><td align="left">1.64&#x02009;&#x000b1;&#x02009;0.35</td><td align="left">0.12&#x02009;&#x000b1;&#x02009;0.03</td><td align="left">0.60&#x02009;&#x000b1;&#x02009;0.06</td><td align="left">0.81&#x02009;&#x000b1;&#x02009;0.09</td><td align="left">1.97&#x02009;&#x000b1;&#x02009;0.22</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Values are expressed as nM (mean&#x02009;&#x000b1;&#x02009;SD, <italic>n</italic>&#x02009;=&#x02009;3); &#x0201c;-&#x0201d; indicate not active up to 100&#x000a0;&#x003bc;g/mL concentration; half-maximal inhibitory concentration (IC<sub>50</sub>) and minimum inhibitory concentration (MIC) values are lowest concentration of samples exhibiting percentage growth inhibition of 50% and&#x02009;&#x02265;&#x02009;90%, respectively, relative to the growth control</p></table-wrap-foot></table-wrap></p><p id="Par15">Furthermore, compounds <bold>1&#x02013;3</bold> were tested against MDA-MB-231, HT-3, and SKOV3 human cancer cell lines for their cytotoxicity. Fig. S1 represents the percentage of cytotoxicity and IC<sub>50</sub> values obtained against MDA-MB-231, HT-3, and SKOV3 cancer cell lines through MTT cell proliferation assay. At 100&#x000a0;&#x000b5;g/mL concentration, compounds <bold>1</bold> and <bold>3</bold> exhibited&#x02009;~&#x02009;44 and&#x02009;~&#x02009;53% inhibition, respectively, of MDA-MB-231 and HT-3, suggesting the biocompatible nature of these compounds. Compound <bold>2</bold> showed the least cytotoxicity up to 100&#x000a0;&#x003bc;g/mL concentration against the tested series of cancer cell lines. The tested concentration was nearly ten times greater than the detected MIC values for <italic>M.t</italic> in ex vivo conditions. Overall, the cytotoxicity results suggest the biocompatible nature of compounds <bold>1</bold>&#x02013;<bold>3</bold>.</p><p id="Par16">To conclude, the present work provides the first evidence for the presence of antimycobacterial compounds in <italic>B. vahlii</italic>. Hence, we report the bioassay-guided isolation of marker compounds <bold>1&#x02013;2</bold> from the bark of <italic>B. vahlii,</italic> possessing significant inhibitory actions against non-virulent <italic>M.t</italic> strains (both in vitro and ex vivo). This study supports the prediction of predominant binding mode(s) of compounds <bold>1</bold> and <bold>2</bold> within <italic>M.t</italic> proteins (like DprE1) that help to recognize the ligand&#x02013;protein interactions and establish a structural basis for inhibition of <italic>M.t</italic> strains.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec9"><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13205_2021_2672_MOESM1_ESM.doc"><caption><p>Supplementary file1 (DOC 2211 KB)</p></caption></media></supplementary-material></p></sec></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam for providing the necessary facilities to complete the present work. The authors would also like to thank Adam F. Johnson (Institute of Research and Development, Duy Tan University, Danang, Vietnam) for the critical reading of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Author&#x02019;s contribution</title><p>T-TN proposed and monitored the biological assays and co-wrote the manuscript. AK and HVH helped with isolation and biological evaluations. VBT conceived the study, analyzed the data, and wrote the manuscript. All authors have read and approved the manuscript.</p></notes><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par17">The authors declare that they have no conflict of interest in the publication.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="other">Baldisseri DM, Biospin B (2018) Practical aspects of fragment-based screening experiments in TopSpin. Brucker. <ext-link ext-link-type="uri" xlink:href="https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/MagneticResonance/NMR/brochures/FBS_appsnote_T169075.pdf">https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/MagneticResonance/NMR/brochures/FBS_appsnote_T169075.pdf</ext-link>. Accessed on 28 Dec 2020</mixed-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>Warren</surname><given-names>SA</given-names></name><name><surname>Salamon</surname><given-names>H</given-names></name><etal/></person-group><article-title>Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli</article-title><source>Lancet</source><year>1999</year><volume>353</volume><fpage>44</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(98)03406-0</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boonphong</surname><given-names>S</given-names></name><name><surname>Puangsombat</surname><given-names>P</given-names></name><name><surname>Baramee</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bioactive compounds from <italic>Bauhinia purpurea</italic> possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities</article-title><source>J Nat Prod</source><year>2007</year><volume>70</volume><fpage>795</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1021/np070010e</pub-id><pub-id pub-id-type="pmid">17480099</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitturi</surname><given-names>BR</given-names></name><name><surname>Chanti</surname><given-names>DB</given-names></name><name><surname>Tatipamula</surname><given-names>VB</given-names></name><etal/></person-group><article-title>Isolation, structural assignment and synthesis of (S, E)-2-methyloctyl 3-(4-methoxyphenyl) propenoate from the marine soft coral Sarcophyton ehrenbergi</article-title><source>Nat Prod Res</source><year>2015</year><volume>29</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.958742</pub-id><pub-id pub-id-type="pmid">25229804</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chitturi</surname><given-names>BR</given-names></name><name><surname>Tatipamula</surname><given-names>VB</given-names></name><name><surname>Dokuburra</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Pambanolides A-C from the South Indian soft coral Sinularia inelegans</article-title><source>Tetrahedron</source><year>2016</year><volume>72</volume><fpage>1933</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2016.02.056</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzoyem</surname><given-names>JP</given-names></name><name><surname>Guru</surname><given-names>SK</given-names></name><name><surname>Pieme</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Cytotoxic and antimicrobial activity of selected Cameroonian edible plants</article-title><source>BMC Complement Altern Med</source><year>2013</year><volume>13</volume><fpage>78</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-13-78</pub-id><pub-id pub-id-type="pmid">23565827</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagneux</surname><given-names>S</given-names></name></person-group><article-title>The competitive cost of antibiotic resistance in Mycobacterium tuberculosis</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>1944</fpage><lpage>1946</lpage><pub-id pub-id-type="doi">10.1126/science.1124410</pub-id><pub-id pub-id-type="pmid">16809538</pub-id></element-citation></ref><ref id="CR8"><mixed-citation publication-type="other">Glaziou P (2020) Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv. 10.1101/2020.04.28.20079582</mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="other">Global Tuberculosis Report (2020) Tuberculosis. World Health Organization Newsletters. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-topics/tuberculosis#tab=tab_3">https://www.who.int/health-topics/tuberculosis#tab=tab_3</ext-link>. Accessed on 26 Dec 2020</mixed-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paidi</surname><given-names>K</given-names></name><name><surname>Tatipamula</surname><given-names>V</given-names></name><name><surname>Kolli</surname><given-names>M</given-names></name><name><surname>Pedakotla</surname><given-names>V</given-names></name></person-group><article-title>Benzohydrazide incorporated imidazo [1,2-b] pyridazine: synthesis, characterization and in vitro anti-tubercular activity</article-title><source>Int J Chem Sci</source><year>2017</year><volume>15</volume><fpage>172</fpage></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paidi</surname><given-names>KR</given-names></name><name><surname>Tatipamula</surname><given-names>VB</given-names></name><name><surname>Kolli</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Synthesis of imidazo[1,2-b] pyridazine comprised piperazine, morpholine derivatives as potent antimycobacterial agents with in vivo locomotor activity</article-title><source>Anti Infect Agent</source><year>2018</year><volume>15</volume><fpage>131</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.2174/2211352515666170821155217</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakotonirina</surname><given-names>E-CJ</given-names></name><name><surname>Ravaoarisoa</surname><given-names>L</given-names></name><name><surname>Randriatsarafara</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Facteurs associ&#x000e9;s &#x000e0; l&#x02019;abandon du traitement anti-tuberculeux dans la ville d&#x02019;Antananarivo</article-title><source>Madagascar Sante Publique (Paris)</source><year>2009</year><volume>21</volume><fpage>139</fpage><pub-id pub-id-type="doi">10.3917/spub.092.0139</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shetty</surname><given-names>PR</given-names></name><name><surname>Buddana</surname><given-names>SK</given-names></name><name><surname>Tatipamula</surname><given-names>VB</given-names></name><etal/></person-group><article-title>Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity</article-title><source>Brazilian J Microbiol</source><year>2014</year><volume>45</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822014005000022</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Akhtar</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>D</given-names></name></person-group><article-title>A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents</article-title><source>J Microbiol Method</source><year>2011</year><volume>84</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2010.11.013</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Nawale</surname><given-names>LU</given-names></name><name><surname>Arkile</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chemical and biological metal nanoparticles as antimycobacterial agents: a comparative study</article-title><source>Int J Antimicrob Agent</source><year>2015</year><volume>46</volume><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2015.03.014</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>M</given-names></name><name><surname>Bertsch</surname><given-names>A</given-names></name><name><surname>Gr&#x000f6;pl</surname><given-names>C</given-names></name><etal/></person-group><article-title>OpenMS&#x02013;an open-source software framework for mass spectrometry</article-title><source>BMC Bioinformat</source><year>2008</year><volume>9</volume><fpage>163</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-163</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatipamula</surname><given-names>VB</given-names></name><name><surname>Vedula</surname><given-names>GS</given-names></name></person-group><article-title>In vitro anti-inflammatory and cytotoxicity studies of two mangrove associated lichens, Dirinaria consimilis and Ramalina leiodea extracts</article-title><source>Hygeia J drugs Med</source><year>2018</year><volume>10</volume><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.15254/H.J.D.Med.10.2018.174</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatipamula</surname><given-names>VB</given-names></name><name><surname>Vedula</surname><given-names>GS</given-names></name><name><surname>Sastry</surname><given-names>AVS</given-names></name></person-group><article-title>Antarvedisides A-B from manglicolous lichen Dirinaria consimilis (Stirton) and their pharmacological profile</article-title><source>Asian J Chem</source><year>2019</year><volume>31</volume><fpage>805</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.14233/ajchem.2019.21734</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatipamula</surname><given-names>VB</given-names></name><name><surname>Annam</surname><given-names>SSP</given-names></name><name><surname>Nguyen</surname><given-names>HT</given-names></name><etal/></person-group><article-title>Sekikaic acid modulates pancreatic &#x003b2;-cells in streptozotocin-induced type 2 diabetic rats by inhibiting digestive enzymes</article-title><source>Nat Prod Res</source><year>2020</year><pub-id pub-id-type="doi">10.1080/14786419.2020.1775226</pub-id><?supplied-pmid 32498563?><pub-id pub-id-type="pmid">32498563</pub-id></element-citation></ref></ref-list></back></article>